Literature DB >> 21175393

Gonadal hormones and cognitive aging: a midlife perspective.

Victor W Henderson1.   

Abstract

Gonadal steroids affect a variety of brain processes. Cognitive consequences of hormonal changes associated with menopause are of scientific interest and of relevance to public health. Natural menopause is a normal physiological process that can only be directly studied through observational research. Similarly, surgical menopause in humans is rarely directly amenable to experimental research. Causality with respect to cognitive outcomes is, therefore, difficult to infer. Cross-sectional and longitudinal findings from the Melbourne Women's Midlife Health Project, the Study of Women's Health Across the Nation and other midlife cohorts suggest that cognitive consequences of the natural menopausal transition are probably small, at least during midlife and at least for episodic memory, which is a key cognitive domain. The data for episodic memory are the most robust. Midlife episodic memory performance is similar both shortly before and after natural menopause, and serum estradiol concentration in midlife is not associated with episodic memory performance. Effects of natural menopause on other cognitive domains, cognitive consequences of surgical menopause and late-life cognitive consequences of midlife hormonal exposures are less well understood and merit continued study.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21175393      PMCID: PMC3675221          DOI: 10.2217/whe.10.87

Source DB:  PubMed          Journal:  Womens Health (Lond)        ISSN: 1745-5057


  97 in total

Review 1.  Ovarian aging and the perimenopausal transition: the paradox of endogenous ovarian hyperstimulation.

Authors:  Jerilynn C Prior
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

2.  Cognitive function across the life course and the menopausal transition in a British birth cohort.

Authors:  Helen S Kok; Diana Kuh; Rachel Cooper; Yvonne T van der Schouw; Diederick E Grobbee; Michael E J Wadsworth; Marcus Richards
Journal:  Menopause       Date:  2006 Jan-Feb       Impact factor: 2.953

3.  Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model.

Authors:  Xu Yue; Melissa Lu; Techie Lancaster; Phillip Cao; Shin-Ichiro Honda; Matthias Staufenbiel; Nobuhiro Harada; Zhenyu Zhong; Yong Shen; Rena Li
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

4.  Natural history of menopause symptoms in primary care patients: a MetroNet study.

Authors:  Jinping Xu; Monina Bartoces; Anne Victoria Neale; Rhonda K Dailey; Justin Northrup; Kendra L Schwartz
Journal:  J Am Board Fam Pract       Date:  2005 Sep-Oct

5.  A longitudinal study of cognition change during early menopausal transition in a rural community.

Authors:  Jong-Ling Fuh; Shuu-Jiun Wang; Shin-Jung Lee; Shiang-Ru Lu; Kai-Dih Juang
Journal:  Maturitas       Date:  2005-09-27       Impact factor: 4.342

Review 6.  Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research.

Authors:  V W Henderson
Journal:  Neuroscience       Date:  2005-11-28       Impact factor: 3.590

7.  The association between endogenous free testosterone and cognitive performance: a population-based study in 35 to 90 year-old men and women.

Authors:  Petra P Thilers; Stuart W S Macdonald; Agneta Herlitz
Journal:  Psychoneuroendocrinology       Date:  2006-02-17       Impact factor: 4.905

8.  National use of postmenopausal hormone therapy: annual trends and response to recent evidence.

Authors:  Adam L Hersh; Marcia L Stefanick; Randall S Stafford
Journal:  JAMA       Date:  2004-01-07       Impact factor: 56.272

9.  Effects of combination estrogen plus progestin hormone treatment on cognition and affect.

Authors:  Susan M Resnick; Pauline M Maki; Stephen R Rapp; Mark A Espeland; Robert Brunner; Laura H Coker; Iris A Granek; Patricia Hogan; Judith K Ockene; Sally A Shumaker
Journal:  J Clin Endocrinol Metab       Date:  2006-03-07       Impact factor: 5.958

10.  Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.

Authors:  Liqin Zhao; Roberta Diaz Brinton
Journal:  BMC Neurosci       Date:  2006-03-13       Impact factor: 3.288

View more
  11 in total

Review 1.  Cognitive Changes with Reproductive Aging, Perimenopause, and Menopause.

Authors:  Kelly N Morgan; Carol A Derby; Carey E Gleason
Journal:  Obstet Gynecol Clin North Am       Date:  2018-10-25       Impact factor: 2.844

2.  The 2012 hormone therapy position statement of: The North American Menopause Society.

Authors: 
Journal:  Menopause       Date:  2012-03       Impact factor: 2.953

Review 3.  Estrogen and the prefrontal cortex: towards a new understanding of estrogen's effects on executive functions in the menopause transition.

Authors:  Sheila Shanmugan; C Neill Epperson
Journal:  Hum Brain Mapp       Date:  2012-12-14       Impact factor: 5.038

4.  Cognitive Effects of Hormone Therapy Continuation or Discontinuation in a Sample of Women at Risk for Alzheimer Disease.

Authors:  Tonita E Wroolie; Heather A Kenna; Katherine E Williams; Natalie L Rasgon
Journal:  Am J Geriatr Psychiatry       Date:  2015-05-21       Impact factor: 4.105

5.  Three midlife strategies to prevent cognitive impairment due to Alzheimer's disease.

Authors:  V W Henderson
Journal:  Climacteric       Date:  2014-08-17       Impact factor: 3.005

6.  Biological factors and age-dependence of primary motor cortex experimental plasticity.

Authors:  Renato Polimanti; Ilaria Simonelli; Filippo Zappasodi; Mariacarla Ventriglia; Maria Concetta Pellicciari; Luisa Benussi; Rosanna Squitti; Paolo Maria Rossini; Franca Tecchio
Journal:  Neurol Sci       Date:  2015-10-07       Impact factor: 3.307

7.  Hormone therapy at early post-menopause increases cognitive control-related prefrontal activity.

Authors:  Romuald Girard; Elise Météreau; Julie Thomas; Michel Pugeat; Chen Qu; Jean-Claude Dreher
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

8.  Evidence for Cognitive Aging in Midlife Women: Study of Women's Health Across the Nation.

Authors:  Arun S Karlamangla; Margie E Lachman; WeiJuan Han; MeiHua Huang; Gail A Greendale
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

9.  Prospective randomized trial to assess effects of continuing hormone therapy on cerebral function in postmenopausal women at risk for dementia.

Authors:  Natalie L Rasgon; Cheri L Geist; Heather A Kenna; Tonita E Wroolie; Katherine E Williams; Daniel H S Silverman
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

10.  Age at menopause and lifetime cognition: Findings from a British birth cohort study.

Authors:  Diana Kuh; Rachel Cooper; Adam Moore; Marcus Richards; Rebecca Hardy
Journal:  Neurology       Date:  2018-04-11       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.